Form D · Pharmaceuticals

Sancilio & Company, Inc.

Riviera Beach, FL · CIK 0001529063

Offering snapshot reported Jul 15, 2014 · SEC filing

Reported sold
$20M
Offering amount: $20M
Investors reported
9
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
May 20, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 15, 2014Initial$20,000,000No comparison9SEC filing
Mar 1, 2012Initial$2,000,000No comparison2SEC filing
Sep 1, 2011Initial$250,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1M
Finders' fees
$0
Form D file number
021-221133

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Noble Financial Capital Markets15768

Source: Form D, filed Jul 15, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Carla Cox Executive
Alan Dunton Director
Andrew Folmer Executive
Daren Graham Executive
Patrick Gray Director
C. Chad Harrell Executive
Roderick Jackson Director
Dennis Langer Director
Kelly Perkins Director
Stephen Porter Executive
Stephan Porter Executive
Frederick Sancilio Director, Executive
Ted Stover Executive
Thorsteinsson Thorsteinn Executive
Martin Zeiger Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3874 Fiscal Court Suite 100
Riviera Beach, FL, 33404